Sr./Exec Director- Portfolio Publication Strategy and Execution

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Purpose

The Sr. Director, Portfolio Publications Strategy and Execution is accountable for developing the portfolio-level publications strategy for assigned assets and disease states, ensuring that publications are strategically aligned to answer specific customer questions and drive clinical value. This role bridges scientific strategy with publications execution, translating portfolio evidence needs into prioritized, high-impact publication results.

This position provides strategic leadership, scientific expertise, and operational excellence focused on delivering high-quality, compliant scientific publications that serve external collaborators (healthcare providers, payers, patients) and enable Research and Development, Clinical Development, Medical Affairs, and Commercial functions.

Primary Responsibilities

Portfolio-Level Scientific Content Strategy & Cross-Functional Alignment

• Develop and maintain comprehensive scientific content strategy for all assets and indications in the assigned portfolio, mapping evidence across indications to create integrated customer-facing drug development content that address HCP, payer, and patient question gaps.
• Partner with Clinical Development, Medical Affairs, and Business Unit (BU) leadership to align publication strategy with regulatory priorities, clinical development timelines, and post-approval needs; influence asset teams to ensure adequate data collection for planned publications.
• Find opportunities for publication efficiency across asset indications (e.g., harmonized safety and efficacy content, clarity in treat to target and context in efficacy across diverse indications/disease states)
• Define data content and publication scenarios required at each stage of the development lifecycle (preclinical, clinical development, launch, post-launch, lifecycle extension).
• Represent GSC in BU and Portfolio governance forums, providing technical guidance and serving as strategic partner on scientific communication strategy.
• Engage with external authors, publishers, journal editors, and guidance bodies (ISMPP, CSE, regulatory organizations) to understand publication landscape trends, editorial priorities, and evolving standards; leverage external insights to inform portfolio strategy development and ensure the assigned publications portfolio remain competitive and compliant.

Value-Focused Publication Portfolio Strategy & Prioritization

• Work with Clinical Development, Medical Affairs and Commercial partners to review asset/indication Integrated Evidence Plans (IEG), Clinical Care Gaps (CCGs) and Innovation Readiness Plans (IR) to identify and document customer question gaps (HCP, payer, patient questions that evidence must address) across the assigned portfolio.
• Establish framework for mapping each planned publication to specific customer question(s) it is intended to answer
• Apply value-based prioritization framework to determine which publications merit company investment (highest-value manuscripts; eliminate or defer low-value congress content).
• Recommend publication portfolio size and composition for each asset based on evidence maturity, customer question urgency, and cross-functional resource availability.
• Track portfolio publication dissemination and uptake; measure reach and engagement with target audiences
• Provide transparent value/cost data to BU leadership for publication investment decision across the assigned portfolio.

Portfolio Publication Plan Execution & Oversight

• Establish clear governance structure and accountability framework for assigned portfolio publication plan execution; define critical issue protocols and decision-making authority for plan adjustments, prioritization trade-offs, and resource allocation across portfolio assets
• Monitor portfolio publication plan progress and delivery performance against approved portfolio strategy using standard metrics and dashboards; identify risks, bottlenecks, and variance from plan and advance issues with recommended mitigation strategies to BU leadership and GSC execution partners
• Conduct regular portfolio-level reviews with publication execution leads, asset teams, and cross-functional partners to assess progress toward customer question coverage, manuscript delivery targets, and congress volume reductions; facilitate adjustments and rebalancing as needed
• Ensure publication execution plans translate portfolio strategy into asset-level tactics, timelines, and resource requirements; partner with GSC first line managers to align capacity, vendor utilization, and internal staffing to support plan delivery.
• Track and communicate publication outcomes (submissions, publications, presentations, impact metrics) to BU and cross-functional leadership; assess alignment with business objectives and inform future portfolio planning and strategy refinement.

Innovation

• Champion adoption of innovation and technology solutions across publications teams globally, ensuring consistent application of new technology, tools, templates, dissemination channels, and processes across all assets in TA
• Monitor external landscape (publication trends, customer preferences, scientific standards, emerging technologies) to find opportunities for strategy enhancement and improvement; evaluate and pilot new tools and approaches that could improve publications efficiency and impact.
• Partner with GSC capability functions (Publications, Technology/Innovation, Regulatory) to integrate standards and translate emerging innovations into TA-specific implementation plans.
• Elevate performance of colleagues to demonstrate expertise in publication planning and execution, drug development, critical thinking, program/project management and cross-functional leadership.
• As needed, supervise employees, including recruiting, administration of performance management, supporting career development, and talent management.

Performance Elevation

• Build a strong, inclusive team by helping publication leads and writers grow as strategic problem solvers and leaders.
• Elevate performance through better coaching and feedback
• Supervise employees as applicable

Minimum Qualification Requirements

• Bachelor's degree in scientific, healthcare, communications or related field.
• 5 years of experience in pharmaceutical publications, medical writing/scientific communications, clinical development, medical affairs, and/or corporate communications

Other Information/Additional Preferences

• Advanced degree (PhD, PharmD, MD, MBA, MSc, MPH, or equivalent) preferred.
• 3 years of experience in leading/managing a key part of portfolio or business process.
• Expertise in industry standards and guidelines relevant to the role (e.g., Good Publication Practices, ICMJE, PhRMA for scientific communications).
• Demonstrated ability to translate customer needs into scientific strategy and communicate value to diverse audiences (scientists, business leaders, regulators, HCPs).
• Proven ability to influence across a matrixed organization and align collaborators around shared strategy.
• Experience with health economics and outcomes research (HEOR) publication strategy.
• Demonstrated expertise in manuscript and congress abstract publication processes.
• Experience with publication metrics and impact measurement frameworks.
• Proven ability to lead teams and mentor professional development.
• Demonstrated strength in cross-functional collaboration and executive engagement.
• Experience with Integrated Evidence Plans and Clinical Care Gap processes.
• Familiarity with global healthcare landscape and regional publication considerations.

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.

Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia Network, Black Employees at Lilly, Chinese Culture Network, Japanese International Leadership Network (JILN), Lilly India Network, Organization of Latinx at Lilly (OLA), PRIDE (LGBTQ+ Allies), Veterans Leadership Network (VLN), Women’s Initiative for Leading at Lilly (WILL), enAble (for people with disabilities). Learn more about all of our groups.

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location.  The anticipated wage for this position is

Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.

#WeAreLilly